for educational and safety purposes
Every compound in the sci-wiki that affects angiogenesis; the ones you can source are floated to the front, then the reference-only entries. Tap any for the full entry, mechanism, and outlets.
3 sourced · 0 reference
TP-508, known in development as Chrysalin and later given the name rusalatide acetate, is a synthetic 23-amino-acid peptide that copies the receptor-binding domain of human alpha-thrombin. It is a tissue-repair peptide, not a nootropic; the appeal is regenerative. Unlike whole thrombin it has no enzymatic activity, so it does not clot blood; instead it binds a distinct class of cell-surface thrombin receptors and kicks off a cascade of healing signals, including angiogenesis (new blood vessel growth), recruitment of inflammatory and progenitor cells, chemotaxis, and cell proliferation. It has been through real animal work and several human trials in diabetic foot ulcers and distal radius fractures, plus preclinical work in bone regeneration, cartilage repair, heart revascularization, and as an emergency radiation countermeasure. The clinical record is genuinely mixed; early studies looked promising, but the pivotal Phase III fracture trial missed its main clinical endpoint.
The BPC-157/KPV/GHK-Cu Transdermal Serum unites three of the most respected regenerative peptides into a single topical formula built for skin, soft tissue, and recovery support. BPC-157 drives angiogenesis and tissue repair, the melanocortin fragment KPV delivers potent anti-inflammatory action, and the copper tripeptide GHK-Cu remodels collagen and rejuvenates the dermal matrix. Together they form a compelling, multi-pathway serum for anyone seeking accelerated healing and visibly healthier skin.
TB-500 Fragment 17-23 is a short peptide corresponding to the central actin-binding region of thymosin beta-4, a small protein found in nearly all cells that is involved in cell movement and tissue repair. Made up of the seven-amino-acid sequence LKKTETQ, this motif carries much of the parent protein's ability to encourage blood-vessel growth, wound healing, and cell migration in laboratory studies. It is sold in the peptide research-chemical market, has no approved medical use, and rests on evidence drawn almost entirely from cell and animal work.